Trade Ministry launches pharmaceutical policy to double local medicine production

The Ghanaian government has unveiled a new Cabinet-approved policy aimed at doubling domestic medicine production in the country. The Ghana Pharmaceutical Manufacturing Policy, launched by Trade Minister Elizabeth Ofosu-Adjare, seeks to bolster the nation's pharmaceutical industry while creating skilled jobs and establishing Ghana as a key player in West African pharmaceutical manufacturing.

Addressing the country's reliance on imported medicines, which currently make up roughly 70% of the Ghanaian medicine supply, the policy outlines a plan to elevate locally produced medicines from 30% to 60% of the domestic market, with the ultimate goal of achieving 70% local pharmaceutical self-sufficiency as set by President John Mahama.

According to Mrs Ofosu-Adjare, medicines are not ordinary goods, as a nation's health, economy, and sovereignty could be put at risk if it cannot produce its vital medicines. The policy offers a cohesive approach to boost investment, regulation, public procurement, skills development, and regional trade to support local pharmaceutical manufacturers.

Key pillars of the policy include enhancing the quality of locally manufactured medicines to adhere to international standards, expanding market access for domestic producers, and providing affordable, long-term financing. The government plans to assist manufacturers in obtaining World Health Organisation Good Manufacturing Practice certification and prequalification, while also leveraging public procurement and the National Health Insurance Scheme to prioritize high-quality medicines produced within Ghana.

To finance the policy, Mrs Ofosu-Adjare said the government will collaborate with Development Bank Ghana, Ghana EXIM Bank, and GIPA to facilitate long-term funding for pharmaceutical businesses. Additionally, the policy aims to expand the industry's scope beyond packaging into the production of active pharmaceutical ingredients, excipients, and vaccines.